Erectile Dysfunction: It Is Not Always Stress or Low Testosterone

It may begin as a quiet remark between friends: “things have not been the same lately”. It can sound like a joke, a late admission or something carefully avoided. Talking about it does not turn intimacy into a diagnosis. It creates room to separate one difficult night from a change that deserves attention.

Fatigue, alcohol, stress, recent illness or context can affect an erection without establishing erectile dysfunction. A new, recurrent or persistent problem should not automatically be filed under age, nerves or testosterone. Erections depend on blood vessels, nerves, hormones, desire, medicines, sleep, relationships and the brain; mixed causes are common.

What counts as erectile dysfunction—and what may change with age

Erectile dysfunction is the recurrent or persistent inability to achieve or maintain sufficient rigidity for satisfactory sexual activity. It does not prescribe one kind of sex and does not measure masculinity. You do not have to wait six months to ask for help: a recurrent, concerning change or an accompanying symptom can be assessed earlier.

Age may bring a need for more time or stimulation, fewer spontaneous erections and a longer refractory period. That does not make every difficult occasion a disease, nor does it make a new change something to ignore. SIMETAP-ED studied a random population sample of 2,934 adult men in Spain and estimated age-adjusted prevalence at 12.4% in adults, 18.9% over 40 and 48.6% over 70. This 2019 cross-sectional study describes frequency under one definition; it is not any individual's future or a precise 2026 estimate.

The older EDEM study interviewed 2,476 Spanish men aged 25–70. Prevalence was 12.1% by self-assessment and 18.9% using the IIEF erectile-function domain. That gap shows how much the number depends on the question and tool. Spain's urology association continued in 2026 to cite 1.5–2 million affected men, but this is derived from EDEM rather than a new national survey.

Erectile dysfunction causes often overlap

Cause group	Possible clues	What deserves review
Vascular and cardiometabolic	Gradual onset across settings, diabetes, smoking, hypertension, abnormal lipids, kidney or vascular disease	Blood pressure, glucose/A1C, lipids, waist, activity and overall cardiovascular risk
Neurological	Spinal or pelvic injury, neuropathy, stroke, multiple sclerosis, altered sensation or strength	Focused neurological assessment; emergency care for sudden deficits
Hormonal	Lower desire and fewer spontaneous erections with other hypogonadal features; thyroid or pituitary clues in selected cases	Well-timed morning testosterone and, only when indicated, SHBG/free testosterone, LH, FSH, prolactin or thyroid tests
Medicines and substances	Timing with antidepressants, antiandrogens, some antihypertensives, opioids, alcohol, recreational drugs or anabolic steroids	Indication, dose and alternatives with the prescriber; do not stop treatment alone
Surgery, radiotherapy or structure	After pelvic surgery/radiotherapy, trauma, pain, curvature or a plaque	Urology assessment and realistic expectations; discuss sexual effects before cancer treatment when possible
Emotional, relational or situational	Marked variation by situation, performance anxiety, depression, conflict, trauma or preserved erections elsewhere	Psychosexual history without assuming that it is “all in the mind”; specialist support when useful

The categories do not compete. Diabetes may affect vessels and nerves; vascular difficulty may generate performance anxiety; insomnia and alcohol may worsen both. Our guide to chronic stress symptoms keeps the broad stress differential, while the insulin resistance guide explains cardiometabolic testing without turning HOMA-IR into a universal diagnosis.

Erectile dysfunction and heart disease: a signal, not a verdict

ED and cardiovascular disease share risk factors and vascular biology. Princeton IV treats ED as a risk marker and risk-enhancing factor for atherosclerotic cardiovascular disease, particularly when the presentation appears vasculogenic. Observational studies suggest erectile symptoms may precede clinically evident cardiovascular disease by two to five years. This does not prove that ED causes a heart attack or predict one for an individual.

The proportionate response is to estimate risk using the right inputs—age, blood pressure, lipids, diabetes, smoking and history—and then decide whether further assessment would change care. Not everyone needs a stress test, coronary calcium CT or vascular ultrasound. Our coronary calcium score guide explains when imaging may reclassify a decision and when it adds radiation without value.

A person with unstable heart disease, chest discomfort, breathlessness with little effort, fainting or uncertain exercise capacity needs assessment before resuming sexual activity or starting medication. If chest pressure, severe breathlessness or fainting occurs during sex, stop and seek urgent help.

ED is not “male menopause” or a low-testosterone diagnosis

Age-related male hormonal change is usually gradual and is not equivalent to the reproductive transition of menopause. Erectile dysfunction cannot diagnose hypogonadism and does not justify testosterone replacement on its own. Desire, spontaneous erections and vascular function answer different questions.

When symptoms are compatible, testosterone is measured fasting in the morning and confirmed on another day if low; SHBG and free testosterone are reserved for cases where they alter interpretation. Our guide to low testosterone and hypogonadism owns that protocol. It also explains that the meta-analysis used by the Endocrine Society found only a small average erectile-function effect from testosterone (SMD 0.16); TRAVERSE improved desire and sexual activity, not erectile function.

What a basic erectile dysfunction assessment includes

1. Describe the change: onset, frequency, rigidity and duration; spontaneous and masturbatory erections; desire, orgasm and ejaculation; pain, curvature and urinary symptoms.
2. Open the context: relationship, mood, performance anxiety, sleep, alcohol, smoking, drugs, activity, recent illness, pelvic surgery/radiotherapy and previous treatment.
3. Review medicines: prescriptions, over-the-counter products, anabolic steroids and supplements. A possible adverse effect is negotiated, not stopped abruptly.
4. Examine with purpose: blood pressure and heart rate, waist or BMI, pulses, and genitourinary, endocrine, vascular and neurological systems as indicated.
5. Order decision-changing tests: fasting glucose or A1C and lipids if not recent; fasting early-morning total testosterone; further testing only for a clinical hypothesis.
6. Quantify without labelling: the IIEF or SHIM can measure domains and progress but does not diagnose the cause or replace conversation.

Penile Doppler ultrasound, nocturnal monitoring, neurological tests, prolactin, LH, PSA or pituitary imaging are not a routine bundle. They are used for a specific uncertainty, trauma, deformity, suspected vascular/endocrine/neurological disease, verified treatment failure or specialist planning. A semen analysis answers reproductive and testicular questions; it does not diagnose the cause of an erection problem.

The tablet is not the diagnosis: effect size, use and limits

EAU guidance recommends sildenafil, tadalafil, vardenafil or avanafil—PDE5 inhibitors—as first-line treatment when appropriate. They facilitate the vascular response to sexual stimulation; they do not create desire and do not work identically in every setting.

Dose-response trials show a clinically meaningful but imperfect effect. In a 24-week trial, 77% of men assigned sildenafil 50 mg reported improved erections versus 25% on placebo. In a 12-week trial, 67% assigned tadalafil 10 mg reported improvement versus 35% on placebo. These are trial doses and populations, not personal prescribing advice or a guarantee. Choice depends on health, interactions, frequency, preference and adverse effects.

PDE5 inhibitors must never be combined with nitrates, nitric-oxide donors, nicorandil or poppers: blood pressure can fall unpredictably. Headache, flushing, nasal congestion and indigestion are common; tadalafil may cause back or muscle pain and some agents can affect vision. Sudden sight or hearing loss, chest pain or a prolonged erection require immediate care. If a PDE5 inhibitor has been taken, tell the emergency team before they give medication.

When a tablet appears not to work, first verify an authorised product, correct indication, timing, food effects where relevant, sexual stimulation and appropriately guided attempts. One failed occasion is not drug resistance. Do not escalate, combine products or buy online mixtures without supervision.

Stepped treatment: matching the cause, safety and preference

Situation	Proportionate option	Key limit or risk
One difficult occasion with a clear trigger and no red flag	Normalise, reduce the trigger and notice whether it recurs	Do not turn one night into a diagnosis or delay care if the change persists
Recurrent or persistent change	Basic assessment and risk-factor care alongside sexual treatment	Do not make a man “fix all his health” before offering symptom relief
Performance anxiety or relational contribution	Education and cognitive-behavioural/psychosexual therapy, often combined with medical treatment	Do not use “psychological” to dismiss vascular risk
PDE5 inhibitor is appropriate and safe	Individual choice, clear instructions and follow-up for benefit and adverse effects	Contraindicated with nitrates, nicorandil and poppers
PDE5 is unsuitable or insufficient despite correct use	Vacuum device, local/injected alprostadil and urology review	Training, pain, bruising, fibrosis or priapism depending on option
Severe ED and other options fail or are not wanted	Penile prosthesis after informed decision-making in an experienced centre	Irreversible surgery with infection and mechanical-failure risk
Shockwave, PRP, cell or supplement offer	Ask for population, protocol, comparator, absolute effect, regulation and follow-up	Shockwaves: mild average benefit and weak recommendation; PRP/cells: investigational

Physical activity, smoking cessation, sleep and control of diabetes, blood pressure and lipids have benefits of their own and may improve function in selected populations. They should not become a moral test or a condition for receiving treatment. Preventive medicine is about prioritising real risk, not accumulating biomarkers.

Red flags: when not to wait

• A painful erection lasting more than four hours: emergency care; time matters for protecting tissue.
• Chest pain or pressure, severe breathlessness, fainting or marked illness during sexual activity: stop and call emergency services.
• One-sided weakness, speech difficulty, confusion or sudden sensory loss: neurological emergency.
• Trauma with a snap, pain, bruising or deformity: urgent assessment.
• New pain, progressive curvature, a plaque or lump: prompt urology review.
• Persistent blood in urine or semen, a testicular lump, fever or significant urinary symptoms: focused assessment rather than waiting for it to pass.

Frequently asked questions

Does one erection problem mean I have erectile dysfunction?

No. Fatigue, alcohol, stress, illness or context may affect one occasion. Seek advice if the change is new, recurrent, persistent or distressing; sooner if a red flag is present.

Can erectile dysfunction be an early sign of heart disease?

It can be a vascular risk marker, not a coronary diagnosis or a prediction of a heart attack. Blood pressure, smoking, glucose, lipids and overall risk deserve review.

Which tests are usually needed?

Medical, sexual and psychosocial history, focused examination, blood pressure, waist or BMI, glucose/A1C, lipids and fasting morning testosterone. Advanced tests follow the findings.

Can the IIEF-5 or SHIM diagnose the cause?

No. It quantifies function and helps monitor change; it cannot distinguish vascular, hormonal, neurological or emotional causes alone.

Are sildenafil and tadalafil just a quick fix?

No. They are effective first-line treatment for many men. Response does not reveal the cause and non-response does not prove a psychological or hormonal origin.

What must never be combined with them?

Nitrates, nitric-oxide donors, nicorandil and poppers. Cardiovascular safety and the complete medicine list need review first.

Do shockwaves, PRP or supplements regenerate erections?

Regeneration is unproven. Shockwaves may provide a mild benefit in selected men with mild vasculogenic ED; PRP and cells remain investigational and supplements have limited evidence.

When is erectile dysfunction an emergency?

A painful erection lasting more than four hours, chest pressure, severe breathlessness, fainting, new neurological symptoms or major trauma need immediate care.

Sources and certainty

1. European Association of Urology. EAU Guidelines: Management of Erectile Dysfunction. Accessed 12 November 2026.
2. Kloner RA et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. J Sex Med. 2024;21:90–116.
3. National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Erectile Dysfunction. Accessed 12 November 2026.
4. Ruiz-García A et al. Prevalence of erectile dysfunction in Spanish primary care: SIMETAP-ED. Clin Investig Arterioscler. 2019;31:101–110.
5. Martin-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: EDEM. J Urol. 2001;166:569–574.
6. Spanish Association of Urology. Men's sexual health and 2026 andrology update. 10 February 2026.
7. EAU Patient Information. Medicines for erectile dysfunction. Accessed 12 November 2026.
8. European Medicines Agency. Sildenafil citrate: EU risk-management information. 2024.

Method: narrative review of the linked guidelines, consensus and studies, plus Spanish and English SERP review on 12 November 2026. Prevalence estimates are historical and definition-dependent; cardiovascular associations do not establish causality. This article is educational and is not a substitute for individual care.

A useful assessment does not look for one universal explanation or an endless test panel. At Progevita, we can help organise sexual history, cardiovascular and metabolic health, sleep, medicines and goals into a measurable plan. If the change keeps happening and you want to understand it without judgement or shortcuts, you can request an initial assessment.